{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:01Z","timestamp":1793330821840,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research and Innovation department of Medway NHS Foundation Trust"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.critrevonc.2020.103208","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T12:20:07Z","timestamp":1609158007000},"page":"103208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Melanoma of unknown primary: New perspectives for an old story"],"prefix":"10.1016","volume":"158","author":[{"given":"Stergios","family":"Boussios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0991","authenticated-orcid":false,"given":"Elie","family":"Rassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Samartzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Sheriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alejandro","family":"P\u00e9rez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2020.103208_bib0005","first-page":"1816","volume":"79","author":"Anbari","year":"1997"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0010","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0015","unstructured":"https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/16-Melanoma-of-skin-fact-sheet.pdf."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archsurg.1975.01360140040008","article-title":"Malignant melanoma: the patient with an unknown site of primary origin","volume":"110","author":"Baab","year":"1975","journal-title":"Arch. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2014.09.029","article-title":"Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies","volume":"72","author":"Bae","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2273.1994.tb01203.x","article-title":"Lymph node metastases in the neck and parotid gland from an unknown primary melanoma","volume":"19","author":"Balm","year":"1994","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4103\/0973-1482.148680","article-title":"Unusual presentation of melanoma of unknown primary origin: a case report and review of literature","volume":"11","author":"Bankar","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/07357900802027073","article-title":"Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma","volume":"26","author":"Bedikian","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence and significance","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0050","article-title":"Metastatic melanoma with unknown primary melanoma (MUP): a case report","volume":"2","author":"Bolognesi","year":"2020","journal-title":"OSP J. Case Rep."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0","article-title":"Metastatic melanoma of unknown primary","volume":"49","author":"Chang","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0065","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0070","article-title":"Metastatic melanoma of uncertain primary with 5-year durable response after conventional therapy: a case report with literature review","volume":"2018","author":"Chantharasamee","year":"2018","journal-title":"Case Rep. Oncol. Med."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0075","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000658-199111000-00014","article-title":"Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis","volume":"214","author":"Coit","year":"1991","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/lary.5540870511","article-title":"Melanoma of the head and neck","volume":"87","author":"Conley","year":"1977","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2012.12.953","article-title":"Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children","volume":"68","author":"Cordoro","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0095","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.21835","article-title":"Metastatic melanoma to lymph nodes in patients with unknown primary sites","volume":"106","author":"Cormier","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0100","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ophtha.2013.07.037","article-title":"Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach","volume":"120","author":"Dalal","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0105","first-page":"341","article-title":"Malignant melanoma of unknown primary origin","volume":"117","author":"Das Gupta","year":"1963","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejca.2012.09.005","article-title":"Melanoma of unknown primary origin: a population-based study in the Netherlands","volume":"49","author":"De Waal","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00008390-200512000-00008","article-title":"Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour?","volume":"15","author":"de Wilt","year":"2005","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(18)30142-6","article-title":"Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial","volume":"19","author":"Dummer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdt411","article-title":"Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas","volume":"25","author":"Egberts","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CMR.0000000000000048","article-title":"Melanomas of unknown primary frequently harbor TERT-promoter mutations","volume":"24","author":"Egberts","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(03)01280-4","article-title":"Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials","volume":"4","author":"Eigentler","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0145","first-page":"1995","article-title":"Prognostic correlations and response to treatment in advanced metastatic malignant melanoma","volume":"34","author":"Einhorn","year":"1974","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0150","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/ijc.32631","article-title":"The real-world outcome of metastatic melanoma: unknown primary vs. known cutaneous","volume":"145","author":"Ellebaek","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13256-016-1117-y","article-title":"Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: a case report","volume":"10","author":"El-Tani","year":"2016","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/DAD.0b013e318165641a","article-title":"Complete regression of primary malignant melanoma","volume":"30","author":"Emanuel","year":"2008","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0165","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1002\/cam4.2252","article-title":"Melanoma incidence, recurrence, and mortality in an integrated healthcare system: a retrospective cohort study","volume":"8","author":"Feigelson","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0170","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1677139","article-title":"Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results","volume":"8","author":"Gambichler","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0175","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.19.03034","article-title":"Prognosis of patients with stage III melanoma according to american joint committee on cancer version 8: a reassessment on the basis of 3 independent stage III melanoma cohorts","volume":"38","author":"Garbe","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0180","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000658-198001000-00018","article-title":"Clinical aspects of unknown primary melanoma","volume":"191","author":"Giuliano","year":"1980","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0190","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1245\/s10434-014-3799-y","article-title":"Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site","volume":"21","author":"Gos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00262-005-0018-5","article-title":"Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients","volume":"55","author":"Haanen","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0200","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0205","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02523659","article-title":"Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?","volume":"7","author":"Hsueh","year":"2000","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0210","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/ijc.28318","article-title":"Patients undergoing Lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome","volume":"133","author":"Hughes","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/bjs.1800770625","article-title":"Lymph node metastasis from melanoma with an unknown primary site","volume":"77","author":"Jonk","year":"1990","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.04.007","article-title":"Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature","volume":"78","author":"Kamposioras","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008390-200502000-00013","article-title":"Melanoma of unknown primary: experience at massachusetts general hospital and dana-farber cancer institute","volume":"15","author":"Katz","year":"2005","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11845-009-0405-6","article-title":"Melanoma of unknown origin: a case series","volume":"179","author":"Kelly","year":"2010","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0235","first-page":"e5324","article-title":"Combined immunotherapy in metastatic melanoma with unknown primary","volume":"11","author":"Khan","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0240","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjc.6604482","article-title":"Phase II trial of imatinib mesylate in patients with metastatic melanoma","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jso.2930240213","article-title":"Unknown primary melanoma","volume":"24","author":"Klausner","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","article-title":"Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials","volume":"26","author":"Korn","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0255","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1200\/JCO.2006.08.8310","article-title":"Melanoma in children and teenagers: an analysis of patients from the national cancer data base","volume":"25","author":"Lange","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0260","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2007.14.0285","article-title":"Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma","volume":"26","author":"Lee","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0270","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1200\/JCO.2008.18.9845","article-title":"Improved survival for stage IV melanoma from an unknown primary site","volume":"27","author":"Lee","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0275","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/IGC.0000000000000198","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas","volume":"24","author":"Leitao","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jamcollsurg.2003.08.012","article-title":"Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors","volume":"198","author":"Litvak","year":"2004","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0285","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0290","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0295","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-Mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.2930190308","article-title":"Malignant melanoma with unknown primary site","volume":"19","author":"Lopez","year":"1982","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0305","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CMR.0000000000000643","article-title":"External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?","volume":"30","author":"Madu","year":"2020","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0310","first-page":"547","article-title":"Blue nevus of the lymph node capsule. Report of a case","volume":"84","author":"Mancini","year":"1992","journal-title":"Pathologica"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0315","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.3748\/wjg.v13.i29.4027","article-title":"Malignant gastrointestinal melanomas of unknown origin: should it be considered primary?","volume":"13","author":"Manouras","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0320","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00000658-196406000-00013","article-title":"Malignant melanoma: report of 203 patients","volume":"159","author":"McSwain","year":"1964","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0325","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/bjs.1800641114","article-title":"Occult primary malignant melanoma: factors influencing survival","volume":"64","author":"Milton","year":"1977","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007611-198603000-00007","article-title":"Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion","volume":"79","author":"Muchmore","year":"1986","journal-title":"South. Med. J."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0335","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1288\/00005537-199410000-00002","article-title":"Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site","volume":"104","author":"Nasri","year":"1994","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000637-199201000-00021","article-title":"Metastatic melanoma with an unknown primary","volume":"28","author":"Norman","year":"1992","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0345","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000155878","article-title":"Baseline staging of melanoma with unknown primary site: the value of serum s100 protein and positron emission tomography","volume":"217","author":"Oberholzer","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0350","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PAP.0000000000000246","article-title":"Immunohistochemistry as a genetic surrogate in dermatopathology: pearls and pitfalls","volume":"26","author":"Oh","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0355","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of sex-specific incidence of melanoma","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0360","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00000658-195212000-00001","article-title":"End results in the treatment of malignant melanoma; a report of 1190 cases","volume":"136","author":"Pack","year":"1952","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.2930230104","article-title":"Metastatic malignant melanoma of unknown primary origin: a study of 30 cases","volume":"23","author":"Panagopoulos","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0370","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mpo.2950240509","article-title":"Malignant melanocytic lesions of unknown primary site in children and adolescents","volume":"24","author":"Pappo","year":"1995","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0375","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CMR.0b013e32834577ec","article-title":"Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009","volume":"21","author":"Pfeil","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0380","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdp325","article-title":"Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study","volume":"21","author":"Quaglino","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0385","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jso.20592","article-title":"Metastatic melanoma in the breast: a report of 27 cases","volume":"94","author":"Ravdel","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0390","first-page":"335","article-title":"Metastatic malignant melanoma with an unknown primary","volume":"156","author":"Reintgen","year":"1983","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0395","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1159\/000453592","article-title":"Unknown primary melanoma: worldwide survey on clinical management","volume":"232","author":"Ribero","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0400","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00238-017-1363-2","article-title":"Do melanoma patients with melanoma of unknown primary have better survival than patients with melanoma of known primary?","volume":"41","author":"R\u00f8dgaard","year":"2018","journal-title":"Eur. J. Plast. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0405","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40257-017-0325-6","article-title":"Advanced melanoma: current treatment options, biomarkers, and future perspectives","volume":"19","author":"Rozeman","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0410","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1524-4725.2010.01562.x","article-title":"Melanoma without a detectable primary site with metastases to lymph nodes","volume":"36","author":"Rutkowski","year":"2010","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0415","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9610(85)90165-5","article-title":"Melanoma metastatic to cervical and parotid nodes from an unknown primary site","volume":"150","author":"Santini","year":"1985","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CMR.0b013e328333bc04","article-title":"Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre","volume":"20","author":"Savoia","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J","article-title":"Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations","volume":"80","author":"Schlagenhauff","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0430","series-title":"Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications","article-title":"Melanoma of unknown primary","author":"Scott","year":"2018"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0435","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000478-198702000-00008","article-title":"Malignant melanoma primary in lymph node. The case of the missing link","volume":"11","author":"Shenoy","year":"1987","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0440","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V","article-title":"Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis","volume":"72","author":"Sirott","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0445","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases","volume":"18","author":"Smith","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0450","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9610(83)90227-1","article-title":"Cervical node metastasis of occult origin","volume":"146","author":"Spiro","year":"1983","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0455","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1468-3083.2006.01355.x","article-title":"Possible role of dermoscopy in the detection of a primary cutaneous melanoma of unknown origin","volume":"20","author":"Stante","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0460","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10434-999-0255-5","article-title":"Positive iliac and obturator nodes in melanoma: survival and prognostic factors","volume":"6","author":"Strobbe","year":"1999","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0465","first-page":"400","article-title":"Patient characteristics, treatment, and outcome of unknown primary melanoma in the United States for the years 1981 and 1987","volume":"62","author":"Sutherland","year":"1996","journal-title":"Am. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0470","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/jso.21994","article-title":"Extensive screening for primary tumor is redundant in melanoma of unknown primary","volume":"104","author":"Tos","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0475","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000478050","article-title":"Treatment outcomes for metastatic melanoma of unknown primary in the new era: a single-institution study and review of the literature","volume":"93","author":"Utter","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0480","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/cancers7030849","article-title":"Treatment of regional metastatic melanoma of unknown primary origin","volume":"7","author":"van Beek","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0485","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1245\/s10434-014-3679-5","article-title":"Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease","volume":"21","author":"van der Ploeg","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0490","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/1097-0142(19911215)68:12<2579::AID-CNCR2820681209>3.0.CO;2-G","article-title":"Treatment of unknown primary melanoma","volume":"68","author":"Velez","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0495","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.32229","article-title":"Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: a dutch population-based study","volume":"146","author":"Verver","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0500","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1008201931959","article-title":"Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study","volume":"9","author":"Vijuk","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0505","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archotol.125.6.635","article-title":"Malignant melanomas of the parotid: comparison of survival for patients with metastases from known vs unknown primary tumor sites","volume":"125","author":"Wang","year":"1999","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066953","article-title":"Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour","volume":"8","author":"Weide","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2020.103208_bib0515","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archsurg.1987.01400240026003","article-title":"Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site","volume":"122","author":"Wong","year":"1987","journal-title":"Arch. Surg."},{"key":"10.1016\/j.critrevonc.2020.103208_bib0520","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.2004.022509","article-title":"Cancer Genome Project. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs","volume":"58","author":"Wong","year":"2005","journal-title":"J. Clin. Pathol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820303449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820303449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:36:13Z","timestamp":1760902573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820303449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":104,"alternative-id":["S1040842820303449"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103208","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma of unknown primary: New perspectives for an old story","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103208"}}